PUBLISHER: DataM Intelligence | PRODUCT CODE: 1575743
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1575743
Overview
Global Gynecological Devices Market reached US$ 15.4 billion in 2023 and is expected to reach US$ 26.9 billion by 2031, growing at a CAGR of 6.8% during the forecast period 2024-2031
Gynecological devices are medical tools and equipment used to diagnose, treat, and manage conditions related to the female reproductive system. They support both preventive and therapeutic approaches, and are used in various applications such as prenatal care, cancer screening, and infertility treatments. From basic tools like speculums and colposcopes to advanced technologies like robotic surgical systems and ultrasound machines, they enhance women's health outcomes and quality of life.
Market Dynamics: Drivers & Restraints
Advancements in the gynecological devices
Advanced laparoscopic robotic surgery is used in gynaecology for procedures like hysterectomies, myomectomies, endometriosis resection, and pelvic organ prolapse repairs. Its precision reduces the risk of damage to surrounding tissues and organs, resulting in fewer complications. Smaller incisions reduce postoperative pain, hospital stays, and recovery times. The enhanced visualisation and maneuverability improve the surgeon's ability to remove endometrial implants and fibroids, increasing procedure success rates.
For instance, in April 2024, the Franche-Comte Polyclinic, part of ELSAN, the leading private hospital group in France, and Moon Surgical, a French-American pioneer in collaborative robotics, announced that the Maestro System is now being used clinically in gynecological laparoscopic procedures.
Stringent regulatory requirements
The global gynecological devices market faces challenges such as stringent regulatory requirements, high costs, shortage of skilled healthcare professionals, cultural and social stigmas, and complications and risks. These factors can hinder the growth of the market, especially in low-income regions, and limit access to advanced gynecological procedures. Additionally, cultural and social stigmas can create barriers to awareness and usage, and complications and risks may lead to reluctance among patients and healthcare providers.
The global gynecological devices market is segmented based on product type, application, end user and region.
The diagnostic devices from the product type segment accounted for approximately 41.3% of the gynecological devices market share
The diagnostic devices from the product type segment accounted for approximately 41.3%. Diagnostic devices, such as ultrasound systems, colposcopes, hysteroscopes, and mammography machines, are vital in the global gynecological devices market for early detection, diagnosis, and monitoring of various conditions like cervical cancer, ovarian cysts, endometriosis, and other reproductive health disorders. Advancements in imaging technologies have improved the accuracy and efficiency of these diagnostic tools, leading to better patient outcomes and promoting preventive care and treatment planning.
For instance, in Septembe 2024, Samsung Medison, a global medical equipment company, will showcase its HERA Z20 ultrasound system at the 34th annual ISUOG World Congress 2024 in Budapest. The premium ultrasound system, which is considered the most important in the field of OB&GYN ultrasound, features advanced AI diagnostic assistance features to improve women's and fetuses' health. The Live ViewAssist feature provides real-time diagnosis location, reduces measurement time, and increases accuracy by automatically classifying cross sections and providing measurement results for the entire quarter of OB&GYN.
North America is estimated to hold about 38.4% of the total market share throughout the forecast period
North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to novel product launches, FDA approvals, presence of a well-established healthcare infrastructure, rising levels of awareness regarding the availability of diagnostic tests & treatments, and developed reimbursement coverage.
For instance, in September 2022, Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the market launch of the Guardenia Contained Extraction System. Guardenia is the latest innovation in their contained tissue extraction product portfolio for gynecological procedures and is manufactured by Advanced Surgical Concepts (ASC) Ltd. of Bray, Ireland.
The major global players in the market include B. Braun Melsungen AG, Medtronic Plc, Cooper Surgical, Inc, Richard Wolf GmbH, Hologic, Inc, Boston Scientific Corporation, Stryker Corporation, Karl Storz GmbH & Co. KG, Ethicon, Inc, MedGyn Products among others.
The global gynecological devices market report would provide approximately 64 tables, 61 figures, and 186 pages.
LIST NOT EXHAUSTIVE